Tekla Capital Management LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2020$744,000
+23.6%
71,3400.0%0.03%
+3.7%
Q1 2020$602,000
-3.5%
71,3400.0%0.03%
+12.5%
Q4 2019$624,000
-18.8%
71,3400.0%0.02%
-29.4%
Q3 2019$768,000
-15.3%
71,3400.0%0.03%
-8.1%
Q2 2019$907,000
-67.2%
71,3400.0%0.04%
-67.0%
Q1 2019$2,767,000
+63.1%
71,340
-14.4%
0.11%
+53.4%
Q4 2018$1,696,000
-55.6%
83,3400.0%0.07%
-47.5%
Q3 2018$3,821,000
-22.5%
83,3400.0%0.14%
-25.7%
Q2 2018$4,930,000
+29.4%
83,340
+48.9%
0.19%
+26.4%
Q1 2018$3,810,000
-20.4%
55,985
+15.7%
0.15%
-20.0%
Q4 2017$4,784,000
-62.1%
48,392
-54.1%
0.18%
-59.1%
Q3 2017$12,633,000
-28.6%
105,495
-47.9%
0.45%
-31.1%
Q2 2017$17,702,000
+82.9%
202,537
-22.2%
0.66%
+74.9%
Q1 2017$9,679,000
+21.2%
260,2000.0%0.38%
+10.3%
Q4 2016$7,988,000
-54.2%
260,2000.0%0.34%
-49.3%
Q3 2016$17,446,000
+125.1%
260,2000.0%0.67%
+112.3%
Q2 2016$7,751,000
+1.4%
260,2000.0%0.32%
-2.8%
Q1 2016$7,642,000
-62.5%
260,2000.0%0.32%
-56.1%
Q4 2015$20,400,000
+92.5%
260,200
+85.1%
0.74%
+94.2%
Q3 2015$10,595,000
-45.2%
140,600
-24.3%
0.38%
-80.3%
Q1 2014$19,351,000
+0.6%
185,8200.0%1.93%
-4.3%
Q4 2013$19,238,000
-21.9%
185,820
-59.5%
2.02%
-26.3%
Q3 2013$24,620,000
-22.0%
458,816
-35.5%
2.74%
-36.2%
Q2 2013$31,583,000711,8004.30%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders